Back to the 2012 Conference

Sunday, April 22, 2012
8:00 a.m.-5:30 p.m.

• Laura McNicholas, MD, Philadelphia Veterans Administration Medical Center, Philadelphia, PA
• Susan Neshin, MD, JSAS Healthcare, Inc., Neptune, NJ
• J.Thomas Payte, MD, Colonial Management Group, LP, Orlando, FL
• Trusandra Taylor, MD , JEVS Human Services, Philadelphia, PA

This course is recommended for clinicians with experience and/or interest in the medication-assisted treatment of opioid dependence. This program provides basic and state-of-the-art information. The curriculum is updated to include current consensus guidance for best practice treatment for opioid addiction. Topics include overview of opioid dependence, epidemiology, opioid pharmacology/ neurobiology; evidence-based treatment options, patient ssessment/selection, special populations, induction and maintenance protocols, pain management, drug-to-drug interactions, adverse effects, methadone deaths, managing medical/psychiatric problems, drug testing, regulatory issues, an accreditation update, risk management and an overview of buprenorphine.

Participants will receive a comprehensive syllabus with reference and resource materials. The curriculum will include relevant case study discussion with audience participation to facilitate the learning process. To further integrate the educational objectives, participants are encouraged to discuss challenging problems and clinical issues to facilitate understanding of didactic principles.

Four experienced opioid treatment program medical directors will conduct the program, focusing on the goal for participants to acquire the essential knowledge and skills necessary to deliver safe and effective medication-assisted treatment for patients with opioid dependence.

The $225.00 registration fee includes a morning coffee service and luncheon.

Additional Fees Apply – Please see Registration Form